| PERIOD ENDING | 31-Dec-07 | 31-Dec-06 | 31-Dec-05 | | Total Revenue | 81,109,143 | 67,532,073 | 68,392,913 | | Cost of Revenue |
-
| 10,170,918 |
-
| | | Gross Profit | 81,109,143 | 57,361,155 | 68,392,913 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 22,124,714 | 19,362,980 | 35,784,134 | | Non Recurring |
-
|
-
| 3,277,222 | | Others | 201,667 | 577,632 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 58,782,763 | 37,420,544 | 29,331,557 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 58,782,763 | 37,420,544 | 29,331,557 | | Interest Expense | 47,968,270 | 25,687,394 | 22,300,467 | | Income Before Tax | 10,814,493 | 11,733,150 | 7,031,090 | | Income Tax Expense | 751,586 | 1,960,175 | 1,030,831 | | Minority Interest | (4,453,549) | (2,978,415) | (1,543,206) | | | | Net Income From Continuing Ops | 5,609,358 | 6,794,561 | 4,457,053 | | | Non-recurring Events | | Discontinued Operations |
-
| 2,518,935 | (20,525) | | Extraordinary Items |
-
| (19,692) |
-
| | Effect Of Accounting Changes |
-
|
-
| 10,643 | | Other Items |
-
|
-
|
-
| | | | Net Income | 5,609,358 | 9,293,804 | 4,447,170 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,609,358 | $9,293,804 | $4,447,170 |
|
0.34% Nasdaq 
Income Statement
